Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (8772)

« Back to Publications

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

Sallman DA. et al, (2026), J Clin Oncol

The challenge and promise of studying human antigen-specific T cells.

Farrar S. et al, (2026), Nat Rev Immunol

Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention.

Wang L. et al, (2026), Nat Commun

Immunology of pregnancy and sepsis: shared and specific pathways guiding future precision care.

Amarasinghe HE. et al, (2026), EBioMedicine, 130

Thalassaemia.

Piel FB. et al, (2026), Nat Rev Dis Primers, 12

CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.

Brolih S. et al, (2026), Nat Commun

Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference.

Huang D. et al, (2026), Cancer Res, 86, 3106 - 3108

VDJ-REMIX: REpertoire Module Identification and eXploration.

Amin S. et al, (2026), Bioinformatics, 42

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Rampotas A. et al, (2026), Sci Transl Med, 18

TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate

Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111

TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.

Pemmaraju N. et al, (2026), Blood

ChatMDV: Reducing Technical Barriers in Bioinformatics Analysis using Large Language Models.

Kiourlappou M. et al, (2026), Gigascience

IL-4 peptide hydrogel reprograms MSC heterogeneity toward the CD106+ population for enhanced renal repair.

Pan K. et al, (2026), Proc Natl Acad Sci U S A, 123

Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.

Munro J. et al, (2026), Sci Rep

Multiome-based identification of molecular markers for prospective identification of platelet-biased HSCs.

Zhang B. et al, (2026), Stem Cell Reports

Load More

1
2
3
4
5
6
7
...
»